Loading...
Loading...
Veri MedTech Holdings, Inc.
Veri MedTech Holdings, Inc.. Spoken Alpha tracks VRHI's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks VRHI's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters with 70% positive reaction rate
SampleConsistent execution against consensus with the stock following through is the cleanest signal a guidance regime is calibrated. Worth watching for the inflection where execution deteriorates relative to the bar.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for VRHI.
curl https://api.spokenalpha.com/v1/companies/VRHI| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $0.59 | $0.47 | +26.1% | -3.6% | -2.8% |
| Q4 FY2026 | $0.82 | $0.64 | +27.6% | +3.7% | +5.7% |
| Q3 FY2026 | $0.48 | $0.39 | +24.2% | +6.7% | +7.3% |
| Q2 FY2026 | $0.65 | $0.54 | +20.8% | +1.6% | +3.9% |
| Q1 FY2025 | $0.80 | $0.68 | +17.6% | +4.8% | +2.0% |
| Q4 FY2025 | $0.66 | $0.56 | +17.0% | +5.5% | +7.0% |
| Q3 FY2025 | $0.78 | $0.63 | +24.4% | -0.8% | -0.5% |
| Q2 FY2025 | $0.72 | $0.62 | +16.5% | +0.8% | -1.1% |
| Q1 FY2024 | $0.76 | $0.62 | +22.5% | +4.2% | +1.5% |
| Q4 FY2024 | $0.96 | $0.80 | +19.7% | -0.4% | +2.2% |